RIPK2 is associated with the NFKB pathway and seems to have a role in colitis-associated CRC, where the level of expression of RIPK2 was significantly higher in the colonic mucosa of patients with ulcerative colitis compared to controls [20]. Here, NFKB1 is linked to colorectal carcinoma.